Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Therini Bio Pty Ltd

Clinical trials sponsored by Therini Bio Pty Ltd, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New eye injection aims to tackle Diabetes-Related vision loss Results expected Mar 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New eye injection aims to tackle Diabetes-Related vision loss

Disease control Recruiting now

This study tests an experimental drug called THN391, given as an injection into the eye, for people with diabetic macular edema (DME) — a condition where fluid builds up in the retina due to diabetes, causing vision loss. The trial involves 21 adults aged 18 to 80 with DME and vi…

Phase 1 • Sponsor: Therini Bio Pty Ltd • Aim: Disease control

Last updated Sep 21, 2026 13:01 UTC